| P50 | author | Sarah M Collier | Q58326703 |
| | Dan Roden | Q58973971 |
| | Rebecca N. Jerome | Q89949423 |
| | Candace D. McNaughton | Q90443673 |
| | Jill M. Pulley | Q91272668 |
| | Robbert J C Slebos | Q92509305 |
| | Erica A. Bowton | Q114324920 |
| | Quinn Stanton Wells | Q38326092 |
| P2093 | author name string | Xiaoming Wang | |
| | Daniel C Liebler | |
| | Nancy J Brown | |
| | Ray L Mernaugh | |
| | Sara L Van Driest | |
| | William E Alborn | |
| | Cara B Sutcliffe | |
| | Miguel Herrera | |
| | Lindsay J Couch | |
| P2860 | cites work | Pathway mapping and development of disease-specific biomarkers: protein-based network biomarkers | Q26995884 |
| | The human plasma proteome: history, character, and diagnostic prospects | Q28218148 |
| | Utilizing human blood plasma for proteomic biomarker discovery | Q28266015 |
| | The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines | Q28484137 |
| | Biobanks and electronic medical records: enabling cost-effective research | Q28652448 |
| | Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction | Q30978394 |
| | Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery | Q33216990 |
| | Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples | Q63466821 |
| | Differential exoprotease activities confer tumor-specific serum peptidome patterns | Q33230965 |
| | Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record | Q33773017 |
| | Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions | Q33850682 |
| | Enabling genomic-phenomic association discovery without sacrificing anonymity | Q34583874 |
| | Principles of human subjects protections applied in an opt-out, de-identified biobank | Q34788719 |
| | The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum | Q35010986 |
| | Global stability of plasma proteomes for mass spectrometry-based analyses. | Q36208968 |
| | Pre-analytical stability of the plasma proteomes based on the storage temperature | Q36858663 |
| | Development of a large-scale de-identified DNA biobank to enable personalized medicine. | Q37149522 |
| | Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group | Q38063697 |
| | Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study | Q38152257 |
| | The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array | Q38420015 |
| | Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVU. | Q41854190 |
| | Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. | Q41969090 |
| | Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies | Q44400002 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | biobank | Q864217 |
| P304 | page(s) | 140-152 | |
| P577 | publication date | 2015-05-14 | |
| P1433 | published in | Journal of personalized medicine | Q27724740 |
| P1476 | title | Phenotype-Driven Plasma Biobanking Strategies and Methods | |
| P478 | volume | 5 | |